Syngenta Developed MicroRNA Technology to Boost Crop Yields

The company has demonstrated yield increases of up to 10% in international trials and plans a 2027 commercial rollout.

Updated on Sept. 22, 2026 in Botany

Healthy green wheat plants growing in a controlled, indoor agricultural glasshouse, highlighting precise plant development and leaf detail.
Syngenta announced that its EXORT biological technology, which uses plant-derived microRNAs to modulate grain growth, achieved 10% yield increases in recent field trials. AI Illustration. Upload story photo >

Live Poll

Do you support the use of new biological technologies to improve crop yields and food production?

Syngenta has developed a biological technology known as EXORT that utilizes plant-derived microRNAs to modulate biological signaling mechanisms. The company announced the results of 240 field trials conducted between 2022 and 2025, which confirmed yield improvements.

Why it matters

By fine-tuning processes like grain growth and fruit development, this technology aims to increase agricultural output using minimal active compounds. It represents a shift toward precise biological interventions in crop science.

The application requires only 50mg of active compound per hectare, or 100g of total formulated product. Trials recorded a maximum yield increase of 740kg of rice per hectare compared to untreated control groups.

The players

Syngenta

A global agribusiness major focused on crop protection chemicals, seeds, and biological research using genomics and bioinformatics.

The details

Syngenta utilizes genomics and bioinformatics to isolate naturally occurring microRNAs — small, non-coding RNA molecules that regulate gene expression. Through high-throughput phenotyping — the use of automated systems to observe and measure plant physical traits — the company identifies specific extracts that generate repeatable physiological changes. These molecules are then applied to crops to influence growth signaling pathways.

Timeline

  1. 2022 to 2025: Syngenta conducted 240 field trials across 15 countries.

  2. 2027: The company plans a first commercial launch in Latin America.

The Tech Race

This development marks a significant move from traditional RNA interference applications in pest control toward the direct stimulation of plant metabolism. It places Syngenta at the forefront of the race to commercialize small-molecule biologicals for yield optimization.

Farmers in Latin America will gain access to the technology during the 2027 rollout, providing a new method to enhance crop density per hectare. Adoption will likely depend on the price-to-yield ratio compared to existing fertilizers and growth regulators.

The takeaway

The use of microRNAs to steer plant physiology offers a low-volume, high-precision alternative to traditional yield-enhancement inputs. Industry stakeholders should monitor the 2027 launch in Latin America to verify if these controlled trial results hold under large-scale commercial conditions.

What happens next

Syngenta is preparing for a commercial launch of the EXORT product line in Latin American markets, which is scheduled for 2027.

Further reading

For more developments in plant-based biological research, visit the Botany section.

Live Poll

Do you support the use of new biological technologies to improve crop yields and food production?